SpyGlass Pharma, Inc. (NasdaqGS: SGP)
Health Care · Pharmaceuticals · US
$24.92
0.00% today · -5.6% 1Y
SpyGlass Pharma, Inc. (NasdaqGS: SGP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $833.52M and employs 76 people.
Over the last twelve months the share price has lost 5.6%, trading between 17.06 and 32.44.
Tweenvest scores SpyGlass Pharma, Inc. across four factors: quality 44/100, value 84/100. Its strongest factor is value.
SGP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $833.52M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.88
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $32.44
- 52-week low
- $17.06
- Avg volume (3M)
- —
- Shares outstanding
- 33.45M
- Employees
- 76
- Next earnings
- —
About SpyGlass Pharma, Inc.
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
- ISIN
- US85220G1094
- Founded
- 2019
- Listed since
- Feb 6, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sihuan Pharmaceutical Holdings Group Ltd.SEHK: 460 | $848.27M | HK$0.74 | +2.78% |
| Shandong Wit Dyne Health Co.,Ltd.SZSE: 000915 | $847.33M | CN¥24.22 | +1.13% |
| Shanghai Kaibao Pharmaceutical CO.,LtdSZSE: 300039 | $841.72M | CN¥5.39 | +1.70% |
| HK inno.N CorporationKOSDAQ: A195940 | $836.59M | ₩39,700.00 | -1.12% |
| Hunan Jiudian Pharmaceutical Co., Ltd.SZSE: 300705 | $828.42M | CN¥11.23 | +2.93% |
| Jiangsu Jibeier Pharmaceutical Co., Ltd.SHSE: 688566 | $824.45M | CN¥27.46 | -0.94% |
| China Traditional Chinese Medicine Holdings Co. LimitedSEHK: 570 | $814.96M | HK$1.27 | +3.25% |
| Sichuan Goldstone Asia Pharmaceutical Inc.SZSE: 300434 | $807.31M | CN¥13.46 | +4.18% |
Figures last refreshed Oct 11, 2026.